Table of Contents
Key Takeaways:
Lipoprotein(a) may be reported in mg/dL or nmol/L, depending on your laboratory. Lp(a) levels are primarily determined by genetics and generally remain stable throughout life.
Most guidelines consider less than 30 mg/dL (75 nmol/L) to be within the normal range.
Levels between 30 and 50 mg/dL (75-125 nmol/L) are often considered an intermediate or "gray zone."
Levels above 50 mg/dL (125 nmol/L) are generally considered elevated and may be associated with increased cardiovascular risk.
If you've recently received a lipoprotein(a), or Lp(a), test result, it might not be easy to tell if your results are actually normal. And the answer isn't always straightforward.
For one thing, unlike many standard cholesterol tests, lipoprotein(a) range values can be reported in two different units: milligrams per deciliter (mg/dL) or nanomoles per liter (nmol/L).
Plus, medical organizations use slightly different thresholds to define what's considered normal or elevated. This can make the situation even more difficult to understand.
Understanding your result starts with knowing which unit your laboratory used and how current clinical guidelines interpret that number. This guide explains the major lipoprotein(a) normal range recommendations, what the "gray zone" means, and why your healthcare provider should evaluate your Lp(a) level alongside your overall cardiovascular risk profile.
That said, keep in mind that Lp(a) is only one part of your cardiovascular risk profile. Your healthcare provider should interpret your result alongside other risk factors.
What Is the Normal Range for Lipoprotein(a)?
Unlike LDL (low-density lipoprotein) cholesterol, there’s no single universally accepted lipoprotein(a) reference range. Several leading cardiovascular organizations use slightly different categories, although they largely agree on what constitutes elevated risk.
Organization | Normal | Gray Zone | Elevated |
European Atherosclerosis Society (EAS) | <30 mg/dL (<75 nmol/L) | 30–50 mg/dL (75–125 nmol/L) | >50 mg/dL (>125 nmol/L) |
StatPearls / NCBI (2026) | <14 mg/dL | 14–30 mg/dL | 31–50 mg/dL; Highest risk: >50 mg/dL |
No “normal” | Uses thresholds | ≥125 nmol/L (50 mg/dL) increased cardiovascular risk; ≥250 nmol/L (100 mg/dL) substantially higher risk | |
National Lipid Association (NLA) | No “normal” | No “Gray Zone” | >50 mg/dL (>100 nmol/L) poses an enhanced risk |
Researchers continue to emphasize the importance of broader screening. A 2025 UC San Diego study published in JACC Advances found that despite elevated Lp(a) affecting an estimated one in five people, only about 0.2% of the U.S. population had been tested, highlighting a significant gap in cardiovascular risk assessment.
What Are mg/dL and nmol/L?
One of the biggest sources of confusion about levels of lipoprotein(a) is that laboratories use two different units. Many laboratories reported Lp(a) in milligrams per deciliter (mg/dL), which measures the particle's mass.
Increasingly, cardiology societies recommend reporting Lp(a) in nanomoles per liter (nmol/L) because it measures particle concentration rather than particle weight.
Unlike many cholesterol particles, Lp(a) varies considerably in size from person to person because of inherited genetic differences. Two individuals with identical mg/dL values may actually have different numbers of Lp(a) particles.
For this reason, experts recommend nmol/L whenever available because it provides a more standardized assessment.
There is no universal conversion formula between mg/dL and nmol/L. Online calculators can produce misleading results because particle size differs among individuals. If your laboratory reports only mg/dL, your healthcare provider can interpret that value using established clinical guidelines.
What Is the Gray Zone for Lipoprotein(a)?
Generally defined as approximately 30-50 mg/dL (75-125 nmol/L), the "gray zone" isn’t clearly low risk or clearly elevated.
Cardiovascular risk doesn’t suddenly change when someone crosses a specific threshold. Instead, risk exists more so on a continuum and depends on many interacting factors.
If your result falls into the gray zone, your healthcare provider might also consider your:
LDL cholesterol
Blood pressure
Diabetes
Smoking history
Family history of premature heart disease
Age
Other cardiovascular risk factors
Rather than focusing on your Lp(a) value alone, physicians evaluate your complete cardiovascular profile to determine what your result means for you.
What Does a High Lp(a) Number Mean for Your Health?
A high lipoprotein(a) range doesn’t diagnose heart disease, nor is it a guarantee that someone will experience a cardiovascular event. Elevated Lp(a) is just thought of as a risk-enhancing factor.
Major cardiovascular organizations recognize elevated Lp(a) as being associated with increased risk for:
Atherosclerotic cardiovascular disease (ASCVD)
Heart attack
Ischemic stroke
Calcific aortic valve stenosis
According to the American College of Cardiology, every 50 nmol/L increase in Lp(a) has been associated with approximately an 11% increase in ASCVD risk. This is not a prediction for any individual who falls within a range considered concerning, because it doesn't account for the full picture of cardiovascular health at the time of elevated Lp(a).
Someone with elevated Lp(a) but otherwise favorable cardiovascular health may have a different overall risk than someone with elevated Lp(a) combined with uncontrolled LDL cholesterol, high blood pressure, diabetes, or smoking.
Lp(a) is largely inherited. Most experts recommend viewing it as one important piece of your cardiovascular risk assessment rather than the sole determinant of future health.
What Should You Do With Your Lipoprotein(a) Result?
If your lipoprotein(a) levels are elevated, the first step is to talk about the result with your healthcare provider or cardiologist.
Your doctor can help place the number into the context of your overall cardiovascular health and determine whether additional evaluation is appropriate.
Ask about:
Reviewing your LDL cholesterol and complete lipid profile.
Evaluating blood pressure.
Assessing blood sugar or diabetes risk.
Reviewing your family history.
Considering additional cardiovascular testing if appropriate.
Because Lp(a) is primarily determined by genetics, it does not always respond meaningfully to diet, exercise, or most dietary supplements. Instead, healthcare providers typically focus on optimizing other modifiable cardiovascular risk factors that have established benefits.
Current therapies specifically targeting Lp(a) remain limited. Lipoprotein apheresis may be appropriate in some cases, and several medications designed to reduce Lp(a) are currently being studied in late-stage clinical trials. Your healthcare provider can explain whether any emerging therapies may be relevant for your situation.
The Bottom Line on Normal Lp(a) Levels
Understanding your lipoprotein(a) range is an important step toward understanding your overall cardiovascular health. Although different organizations use slightly different thresholds, they consistently recognize elevated Lp(a) as an inherited cardiovascular risk factor that should be interpreted alongside other health information.
If your Lp(a) result is normal, in the gray zone, or elevated, the most valuable next step is to discuss it with your healthcare provider. Together, you can review your overall cardiovascular risk profile, determine whether additional testing is appropriate, and develop a personalized plan focused on established strategies for long-term heart health. As research into Lp(a) continues to advance, informed conversations with your healthcare team remain the best way to understand what your number means for you.
For more educational content around heart health, nattokinase, and lipoprotein(a), check out the rest of the Toku blog.
FAQs
What is the normal range for lipoprotein(a)?
Most guidelines consider Lp(a) below 30 mg/dL (75 nmol/L) to be in the normal range. Levels of 30-50 mg/dL are considered intermediate ("gray zone"), and above 50 mg/dL (125 nmol/L) is generally considered elevated. Different organizations use slightly different thresholds — your doctor can interpret your specific result.
My Lp(a) result is in mg/dL, but my doctor mentioned nmol/L. Are they the same?
No. mg/dL and nmol/L are different units measuring the same thing, and there is no universal formula to convert between them because Lp(a) particles vary in size from person to person. Your doctor can interpret your result in whichever unit your lab used.
What does it mean if my Lp(a) is in the "gray zone"?
The gray zone (approximately 30-50 mg/dL or 75-125 nmol/L) is an intermediate range where cardiovascular risk is less clearly defined. Guidelines recommend evaluating your full cardiovascular risk profile rather than focusing on the Lp(a) number alone. Your doctor can provide personalized guidance.
*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Keep out of reach of children. Consult with your physician before use if you are pregnant, nursing, have a medical condition, or are taking anticoagulants. Discontinue use and consult with your health care professional if you experience any adverse reaction to this product.
Sources:
Lipoprotein A - StatPearls | NCBI Bookshelf
